Evofem Biosciences, Inc.
EVFM
$0.01
$0.0016.00%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.63% | 471.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.63% | 471.01% | |||
| Cost of Revenue | 19.87% | 106.85% | |||
| Gross Profit | -0.57% | 747.92% | |||
| SG&A Expenses | 0.25% | -10.01% | |||
| Depreciation & Amortization | -25.23% | -52.02% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.34% | 1,072.97% | |||
| Operating Income | 21.50% | -482.57% | |||
| Income Before Tax | 11.48% | -285.88% | |||
| Income Tax Expenses | -157.14% | -- | |||
| Earnings from Continuing Operations | 12.05% | -286.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.05% | -286.61% | |||
| EBIT | 21.50% | -482.57% | |||
| EBITDA | 21.23% | -305.04% | |||
| EPS Basic | 9.09% | -283.33% | |||
| Normalized Basic EPS | -90.63% | -281.13% | |||
| EPS Diluted | 30.00% | -10,100.00% | |||
| Normalized Diluted EPS | -90.63% | -9,700.00% | |||
| Average Basic Shares Outstanding | 3.36% | 2.06% | |||
| Average Diluted Shares Outstanding | 3.36% | -98.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||